300255.SZ · 常山药业
China A-shares · RS rating 7 · As of 2026-10-14
| Price | 20.88 CNY |
|---|---|
| 1-day change | -0.8% |
| RS rating (overall / 1M / 3M / 12M) | 7 / 27 / 41 / 4 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 24 / 16 / 16 |
| Industry group (rank) | Medical-Biomed/Biotech (68) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -14.2% |
| Distance from 52-week high | +70.1% |
| Market cap (USD) | $3.0B |